Researchers found these disparities by analyzing data from a 2022-23 federal, population-based survey on drug use, mental health, and behavioral health
"Really only after a drug gets on the market, and sometimes after it's been on the market for many years, do we fully understand a more complete picture of the characteristics of that drug," said Kristine Steffen, NDSU professor of pharmaceutical sciences
Pooled mean follow-up on-treatment for semaglutide users was 193 days (median 157 days, interquartile range (IQR) 85 to 331 days) and for sitagliptin users 195 days (median 160 days, IQR 95 to 322 days)
Blood work tracking HbA1c, fasting glucose, and lipid panels shows metabolic improvements
With this in mind, here were going to take a look at the pharmacokinetics of the two big boys (WeGovy and Mounjaro) and think about the impact those may have on the expected effects with type 1, and potentially the corroloary effects when used for other conditions
It will keep you hydrated